Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

about

Characteristics of first-time varenicline users - A cross-sectional study in Finnish quitters

P2860

Q33576825-F482FAA9-FE51-4236-8801-33C7FD70D378

P2860

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

Item

http://www.wikidata.org/entity/Q57710081

description

im Februar 2013 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в лютому 2013

@uk

name

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

@en

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

@nl

type

Item

label

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

@en

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

@nl

prefLabel

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

@en

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

@nl

P1476

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

@en

P2860

Mortality in relation to smoking: 50 years' observations on male British doctors

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Accuracy of patient recall of opportunistic smoking cessation advice in general practice.

Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.

Effectiveness of the 5-As tobacco cessation treatments in nine HMOs.

Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation

Engaging physicians and pharmacists in providing smoking cessation counseling.

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.

A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

P304

11-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/JSC.2013.2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stuart G. Ferguson

Mai Frandsen

P577

2013-02-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

about

P2860

P2860

Physician and Pharmacist Care of Varenicline Users in a Real-World Setting

description

name

type

label

prefLabel

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577

P356

P1433

P1476

P2860

P304

P31

P356

P433

P478

P50

P577